Julian R. Molina, Jeffrey Ward, Joel R. Hecht, Kedar Kirtane, Rosalyn Marar, Olivia Rose Fankuchen, Jasmine Mitchell, David G. Maloney, Marcela Valderrama Maus, Cathy Eng, Antonious Ziad Hazim, Sandip Pravin Patel, Oliver Dorigo, Kai He, Yanyan Lou, Madappa N. Kundranda, Peter Vu, Jacqueline D. Xuan, Monica Avila, Salman Rafi Punekar. "Initial safety and efficacy of A2B694, a logic-gated mesothelin (MSLN)–targeted Tmod chimeric antigen receptor T-cell (CAR T) therapy in patients with advanced solid tumors with HLA-A*02 loss of heterozygosity (LOH).." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.8579